tradingkey.logo
tradingkey.logo
Search

Upexi Inc

UPXI
Add to Watchlist
0.759USD
-0.061-7.44%
Close 10-30 16:00(ET)
66.93MMarket Cap
LossP/E TTM

About Upexi Inc Company

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Upexi Inc Profile

Ticker SymbolUPXI
Company nameUpexi Inc
IPO dateJun 24, 2021
CEOMarshall (Allan)
Number of employees59
Security typeOrdinary Share
Fiscal year-endJun 24
Address3030 Rocky Point Drive
CityTAMPA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33607
Phone17013535425
Websitehttps://upexi.com/
Ticker SymbolUPXI
IPO dateJun 24, 2021
CEOMarshall (Allan)

Company Executives of Upexi Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Allan Marshall
Mr. Allan Marshall
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.17M
-170.76%
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.17M
-170.76%
Mr. Allan Marshall
Mr. Allan Marshall
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.17M
-170.76%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
760.37K
-13.15%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
760.37K
-13.15%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
760.37K
-13.15%
Mr. Brian Rudick
Mr. Brian Rudick
Chief Strategy Officer
Chief Strategy Officer
538.60K
-74.27%
Mr. Brian Rudick
Mr. Brian Rudick
Chief Strategy Officer
Chief Strategy Officer
538.60K
-74.27%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
75.00K
--
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
75.00K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Allan Marshall
Mr. Allan Marshall
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.17M
-170.76%
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.17M
-170.76%
Mr. Allan Marshall
Mr. Allan Marshall
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.17M
-170.76%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
760.37K
-13.15%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
760.37K
-13.15%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
760.37K
-13.15%

FAQs

Who are the top five shareholders of Upexi Inc?

The top five shareholders of Upexi Inc are: Mr. Allan Marshall

How many institutions hold shares of Upexi Inc (UPXI)?

As of 2026Q1, 122 institutions hold shares of Upexi Inc, with a combined market value of approximately 23.05M, accounting for 34.45% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -188428.00.

What is the biggest source of revenue for Upexi Inc?

In 2026Q1, the Internally manufactured business generated the highest revenue for Upexi Inc, amounting to 4.53M and accounting for 59.85% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.